Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 08-Nov 2017. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 93951901000001114 | Kengrexal 50mg powder for concentrate for solution for injection / infusion vials (The Medicines Company UK Ltd) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 101478501000001115 | Kengrexal 50mg powder for concentrate for solution for injection / infusion vials (Chiesi Ltd) | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Kengrexal 50mg powder for concentrate for solution for injection / infusion vials (The Medicines Company UK Ltd) | Is a | Cangrelor 50mg powder for solution for injection vials | false | Inferred relationship | Existential restriction modifier | ||
| Kengrexal 50mg powder for concentrate for solution for injection / infusion vials (The Medicines Company UK Ltd) | VMP prescribing status (attribute) | VMP valid as a prescribable product | false | Inferred relationship | Existential restriction modifier | ||
| Kengrexal 50mg powder for concentrate for solution for injection / infusion vials (The Medicines Company UK Ltd) | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
| Kengrexal 50mg powder for concentrate for solution for injection / infusion vials (The Medicines Company UK Ltd) | Has specific active ingredient | Cangrelor tetrasodium | false | Inferred relationship | Existential restriction modifier | ||
| Kengrexal 50mg powder for concentrate for solution for injection / infusion vials (The Medicines Company UK Ltd) | Has dispensed dose form | Powder for conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
| Kengrexal 50mg powder for concentrate for solution for injection / infusion vials (The Medicines Company UK Ltd) | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | Cangrelor | false | Inferred relationship | Existential restriction modifier | ||
| Kengrexal 50mg powder for concentrate for solution for injection / infusion vials (The Medicines Company UK Ltd) | Has excipient | Excipient not declared | false | Inferred relationship | Existential restriction modifier | ||
| Kengrexal 50mg powder for concentrate for solution for injection / infusion vials (The Medicines Company UK Ltd) | Is a | Kengrexal | false | Inferred relationship | Existential restriction modifier | ||
| Kengrexal 50mg powder for concentrate for solution for injection / infusion vials (The Medicines Company UK Ltd) | Is a | Actual medicinal product | false | Inferred relationship | Existential restriction modifier | ||
| Kengrexal 50mg powder for concentrate for solution for injection / infusion vials (The Medicines Company UK Ltd) | Has active ingredient | Antiplatelet agent | false | Inferred relationship | Existential restriction modifier | ||
| Kengrexal 50mg powder for concentrate for solution for injection / infusion vials (The Medicines Company UK Ltd) | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | Cangrelor | false | Inferred relationship | Existential restriction modifier | ||
| Kengrexal 50mg powder for concentrate for solution for injection / infusion vials (The Medicines Company UK Ltd) | Has manufactured dose form | Powder for conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
| Kengrexal 50mg powder for concentrate for solution for injection / infusion vials (The Medicines Company UK Ltd) | Has basis of strength substance | Cangrelor | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Kengrexal 50mg powder for concentrate for solution for injection / infusion vials (The Medicines Company UK Ltd) 10 vial | Has AMP | False | Kengrexal 50mg powder for concentrate for solution for injection / infusion vials (The Medicines Company UK Ltd) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR